Viewing Study NCT02502266


Ignite Creation Date: 2025-12-24 @ 4:33 PM
Ignite Modification Date: 2026-02-28 @ 8:50 PM
Study NCT ID: NCT02502266
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2015-07-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Sponsor:
Organization: